Maxalt
Company: Merck
Approval Status: Approved June 1998
Treatment for: Migraine Headaches
Areas: Neurology
| General Information | Clinical Results |
General Information
Maxalt has been approved for the acute treatment of migraine headaches. Maxalt is the first and only migraine drug available not only in conventional tablets, but also in a fast-dissolving tablet formulation (disintegrated on the tongue, no water needed).
Clinical Results
In clinical studies it was found that approximately 70% of patients who took Maxalt 10mg reported pain relief at two hours, while 60% of patients who took the 5mg dose reported pain relief at two hours as well. Both formulations will be made available in 10mg and 5mg strengths.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
